HCW Biologics | D: Filing D
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Wong Hing C
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director Greene Rick S.
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director Giles Lisa M.
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director GARRETT SCOTT T
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Flowers Lee
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Byam Rebecca
HCW Biologics | 8-K: Current report
HCW Biologics | 8-K: Current report
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Rhode Peter
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Flowers Lee
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Rhode Peter
HCW Biologics: Q3 2023 Earnings Report
HCW Biologics | 8-K: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Byam Rebecca
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Wong Hing C
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director Winer Gary M
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Byam Rebecca
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Byam Rebecca
HCW Biologics | 4: Statement of changes in beneficial ownership of securities-Director Winer Gary M
No Data